BCL9L Antikörper (AA 606-751)
Kurzübersicht für BCL9L Antikörper (AA 606-751) (ABIN5611246)
Target
Alle BCL9L Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 606-751
-
Verwendungszweck
- BCL9L Antibody
-
Aufreinigung
- Purified antibody
-
Immunogen
- Purified recombinant fragment of human BCL9L (AA: 606-751) expressed in E. Coli.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
ELISA: 1/10000
FCM: 1/200 - 1/400
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
- BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))
-
Andere Bezeichnung
- BCL9L
-
Hintergrund
-
BCL9L (B-Cell CLL/Lymphoma 9-Like) is a Protein Coding gene. Among its related pathways are Wnt Signaling Pathways: beta-Catenin-dependent Wnt Signaling and Signaling by Wnt. GO annotations related to this gene include transcription coactivator activity and beta-catenin binding. An important paralog of this gene is BCL9.
-
Molekulargewicht
- 157 kDa
-
Gen-ID
- 283149
-
UniProt
- Q86UU0
-
Pathways
- Stem Cell Maintenance
Target
-